Form 8-K - Current report:
SEC Accession No. 0000893220-95-000537
Filing Date
1995-08-17
Accepted
1995-08-17 00:00:00
Documents
4
Period of Report
1995-08-02
Items
Item 2: Acquisition or disposition of assets
Item 7: Financial statements and exhibits
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 8-K, ONCOGENE SCIENCE, INC. 8-K 22716
2 ASSET PURCHASE AGREEMENT DATED JUNE 26, 1995 EX-10.1 139196
3 SUBLEASE DATED AUGUST 2, 1995 EX-10.2 51996
4 NEW PRODUCT LICENSE RIGHT OF FIRST REFUSAL EX-10.3 14109
  Complete submission text file 0000893220-95-000537.txt   229528
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
ONCOGENE SCIENCE INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 95565025
SIC: 2835 In Vitro & In Vivo Diagnostic Substances